Chronic kidney disease (CKD) is a long term condition caused by damage to both kidneys. There is no single cause and the damage is usually irreversible and can lead to ill health. The average prevalence has been reported at 11% in USA and Europe.
Remit and target users
This guideline covers the evidence for the association of specific risk factors with CKD to help identify which individuals are more likely to develop CKD. Guidance is provided on how to diagnose CKD principally using blood and urine tests. The guideline also contains recommendations on how to slow the progression of CKD and reduce the risk of cardiovascular disease.
This guideline will be of value to all health professionals in primary and secondary care involved in the detection and management of patients with CKD.
How this guideline was developed
This guideline was developed using a standard methodology based on a systematic review of the evidence. Further details can be found in SIGN 50: A Guideline Developer’s Handbook .
Keeping up to date
This guideline was issued in 2008 and will be considered for review in three years. The review history, and any updates to the guideline in the interim period, will be noted in the review report.
Use with caution, declaration of interests governance may not be in line with current policy.
Full guideline (PDF)
Quick reference guide (PDF)
Register of Interests
Search narrative (PDF)
Polypharmacy Guidance (PDF)
Copyright permission (PDF)
Contact us firstname.lastname@example.org
SIGN 103, June 2008
ISBN 978 1 905813 30 8
Register of Interest
A register of interest is not available for this guideline. In line with the SIGN Document Retention Schedule (24/07/2010), after publication of this guideline, hard copies of declarations of interest were held at the SIGN Executive offices for one year. The declarations of interest were then archived for a further three years before being destroyed along with other guideline related documents. This schedule has now been revised.